129 related articles for article (PubMed ID: 29137260)
21. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA
J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma.
Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1837-45. PubMed ID: 27342421
[TBL] [Abstract][Full Text] [Related]
23. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
24. The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort.
Mansuet-Lupo A; Bobbio A; Blons H; Becht E; Ouakrim H; Didelot A; Charpentier MC; Bain S; Marmey B; Bonjour P; Biton J; Cremer I; Dieu-Nosjean MC; Sautès-Fridman C; Régnard JF; Laurent-Puig P; Alifano M; Damotte D
Chest; 2014 Sep; 146(3):633-643. PubMed ID: 24676429
[TBL] [Abstract][Full Text] [Related]
25. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic features and prognostic value of epidermal growth factor receptor mutation in patients with pT1a and pT1b invasive lung adenocarcinoma after surgical resection.
Chen S; Yang S; Zhang Y; Xiang J; Zhang Y; Hu H; Sun Y; Fu F; Deng C; Wang S; Li Q; Gu Y; Li Y; Shen X; Ye T
J Thorac Dis; 2021 Sep; 13(9):5496-5507. PubMed ID: 34659816
[TBL] [Abstract][Full Text] [Related]
27. Correlation of Histologic Subtypes and Molecular Alterations in Pulmonary Adenocarcinoma: Therapeutic and Prognostic Implications.
Kim J; Jang SJ; Choi CM; Ro JY
Adv Anat Pathol; 2016 Sep; 23(5):330-8. PubMed ID: 27403614
[TBL] [Abstract][Full Text] [Related]
28. The difference in Ezrin-pAkt signaling axis between lepidic and papillary predominant invasive adenocarcinomas of the lung.
Hata K; Yoshida J; Udagawa H; Hashimoto H; Fujii S; Hishida T; Kuwata T; Aokage K; Kojima M; Ochiai A; Suzuki K; Tsuboi M; Ishii G
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1421-30. PubMed ID: 27059464
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma.
Tsubokawa N; Mimae T; Miyata Y; Sasada S; Yoshiya T; Kushitani K; Takeshima Y; Murakami S; Yokose T; Ito H; Nakayama H; Okada M
Jpn J Clin Oncol; 2016 Nov; 46(11):1015-1021. PubMed ID: 27566971
[TBL] [Abstract][Full Text] [Related]
31. Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes.
Lee G; Lee HY; Jeong JY; Han J; Cha MJ; Lee KS; Kim J; Shim YM
Am J Surg Pathol; 2015 May; 39(5):660-6. PubMed ID: 25724001
[TBL] [Abstract][Full Text] [Related]
32. Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma.
Cai L; Wang J; Yan J; Zeng J; Zhu L; Liang J; Pan C; Huang X; Jin J; Xu Y; Wang F; Shao Y; Xu Q; Xia G; Xing M; Xu X; Jiang Y
Front Oncol; 2020; 10():603671. PubMed ID: 33505917
[TBL] [Abstract][Full Text] [Related]
33. The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations.
Zheng D; Wang R; Zhang Y; Pan Y; Cheng X; Cheng C; Zheng S; Li H; Gong R; Li Y; Shen X; Sun Y; Chen H
Onco Targets Ther; 2016; 9():833-43. PubMed ID: 26955281
[TBL] [Abstract][Full Text] [Related]
34. Cancer cell immunity-related protein co-expression networks are associated with early-stage solid-predominant lung adenocarcinoma.
Nishimura T; Végvári Á; Nakamura H; Fujii K; Sakai H; Naruki S; Furuya N; Saji H
Front Oncol; 2024; 14():1273780. PubMed ID: 38450191
[TBL] [Abstract][Full Text] [Related]
35. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
[TBL] [Abstract][Full Text] [Related]
36. The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma.
Caso R; Sanchez-Vega F; Tan KS; Mastrogiacomo B; Zhou J; Jones GD; Nguyen B; Schultz N; Connolly JG; Brandt WS; Bott MJ; Rocco G; Molena D; Isbell JM; Liu Y; Mayo MW; Adusumilli PS; Travis WD; Jones DR
J Thorac Oncol; 2020 Dec; 15(12):1844-1856. PubMed ID: 32791233
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of oncogenic mutations in lung squamous cell carcinoma with minor glandular component.
Pan Y; Wang R; Ye T; Li C; Hu H; Yu Y; Zhang Y; Wang L; Luo X; Li H; Li Y; Shen L; Sun Y; Chen H
Chest; 2014 Mar; 145(3):473-479. PubMed ID: 24158231
[TBL] [Abstract][Full Text] [Related]
38. Histological subtypes of solitary pulmonary nodules of adenocarcinoma and their clinical relevance.
Hu HD; Wan MY; Xu CH; Zhan P; Zou J; Zhang QQ; Zhang YQ
J Thorac Dis; 2013 Dec; 5(6):841-6. PubMed ID: 24409363
[TBL] [Abstract][Full Text] [Related]
39. Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma.
Cai D; Li H; Wang R; Li Y; Pan Y; Hu H; Zhang Y; Gong R; Pan B; Sun Y; Chen H
Onco Targets Ther; 2014; 7():2127-32. PubMed ID: 25429229
[TBL] [Abstract][Full Text] [Related]
40. EGFR, KRAS, and BRAF mutational profiles of female patients with micropapillary predominant invasive lung adenocarcinoma.
Demirağ F; Yılmaz A; Yılmaz Demirci N; Yılmaz Ü; Erdoğan Y
Turk J Med Sci; 2017 Nov; 47(5):1354-1361. PubMed ID: 29151304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
